These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32557776)

  • 21. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].
    Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö
    Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
    Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
    Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season.
    Galli C; Pellegrinelli L; Bubba L; Primache V; Anselmi G; Delbue S; Signorini L; Binda S; Cereda D; Gramegna M; Pariani E; The Ili Sentinel Physicians Group
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
    Dee K; Goldfarb DM; Haney J; Amat JAR; Herder V; Stewart M; Szemiel AM; Baguelin M; Murcia PR
    J Infect Dis; 2021 Jul; 224(1):31-38. PubMed ID: 33754149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The disappearance of respiratory syncytial virus and influenza viruses in children during the second year of the COVID-19 pandemic - are non-pharmaceutical interventions as effective as vaccines?
    Kışlal FM; Hanilçe Y; Altaş B; Büyükbaşaran ZE; Güven D
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3777-3783. PubMed ID: 37140326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season.
    Milano G; Marchi S; Vicenti I; Biba C; Fiaschi L; Trombetta CM; Lazzeri G; Montomoli E; Manini I
    J Prev Med Hyg; 2024 Mar; 65(1):E11-E16. PubMed ID: 38706768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Karimzadeh S; Bhopal R; Nguyen Tien H
    Epidemiol Infect; 2021 Apr; 149():e96. PubMed ID: 33849679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and Outcome of Coinfections with SARS-CoV-2 and Rhinovirus.
    Le Glass E; Hoang VT; Boschi C; Ninove L; Zandotti C; Boutin A; Bremond V; Dubourg G; Ranque S; Lagier JC; Million M; Fournier PE; Drancourt M; Gautret P; Colson P
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multiplex-NGS approach to identifying respiratory RNA viruses during the COVID-19 pandemic.
    Ramos N; Panzera Y; Frabasile S; Tomás G; Calleros L; Marandino A; Goñi N; Techera C; Grecco S; Fuques E; Coppola L; Ramas V; Morel MN; Mogdasy C; Chiparelli H; Arbiza J; Pérez R; Delfraro A
    Arch Virol; 2023 Feb; 168(3):87. PubMed ID: 36786897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
    Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding the double trouble: A mathematical modelling of co-infection dynamics of SARS-CoV-2 and influenza-like illness.
    Bhowmick S; Sokolov IM; Lentz HHK
    Biosystems; 2023 Feb; 224():104827. PubMed ID: 36626949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.
    Yue H; Zhang M; Xing L; Wang K; Rao X; Liu H; Tian J; Zhou P; Deng Y; Shang J
    J Med Virol; 2020 Nov; 92(11):2870-2873. PubMed ID: 32530499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
    Elaiw AM; Alsulami RS; Hobiny AD
    Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.
    Perez A; Lively JY; Curns A; Weinberg GA; Halasa NB; Staat MA; Szilagyi PG; Stewart LS; McNeal MM; Clopper B; Zhou Y; Whitaker BL; LeMasters E; Harker E; Englund JA; Klein EJ; Selvarangan R; Harrison CJ; Boom JA; Sahni LC; Michaels MG; Williams JV; Langley GE; Gerber SI; Campbell A; Hall AJ; Rha B; McMorrow M;
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1253-1259. PubMed ID: 36201373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.
    Zheng J; Chen F; Wu K; Wang J; Li F; Huang S; Lu J; Huang J; Liu H; Zhou R; Huang Z; Meng B; Yuan Z; Wu X
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009997. PubMed ID: 34843492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract.
    Essaidi-Laziosi M; Alvarez C; Puhach O; Sattonnet-Roche P; Torriani G; Tapparel C; Kaiser L; Eckerle I
    Emerg Microbes Infect; 2022 Dec; 11(1):412-423. PubMed ID: 34931581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season.
    Adams K; Tastad KJ; Huang S; Ujamaa D; Kniss K; Cummings C; Reingold A; Roland J; Austin E; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Reeg L; Leegwater L; McMahon M; Bye E; Poblete M; Landis Z; Spina NL; Engesser K; Bennett NM; Gaitan MA; Shiltz E; Moran N; Sutton M; Abdullah N; Schaffner W; Talbot HK; Olsen K; Staten H; Taylor CA; Havers FP; Reed C; Budd A; Garg S; O'Halloran A; Brammer L
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1589-1596. PubMed ID: 36520656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment.
    Hardick J; Shaw-Saliba K; McBryde B; Gaydos CA; Hsieh YH; Lovecchio F; Steele M; Talan D; Rothman RE;
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115352. PubMed ID: 33639376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus during the COVID-19 pandemic.
    Rezaee D; Bakhtiari S; Jalilian FA; Doosti-Irani A; Asadi FT; Ansari N
    Arch Virol; 2023 Jan; 168(2):53. PubMed ID: 36609722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.